19.17 USD
-0.34 (-1.74%)
19.17 USD
0 (0%)
SLP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. SLP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SLP is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
SLP had positive earnings in the past year.
In the past year SLP had a positive cash flow from operations.
SLP had positive earnings in 4 of the past 5 years.
Each year in the past 5 years SLP had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -49.05%, SLP is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
SLP's Return On Equity of -51.86% is in line compared to the rest of the industry. SLP outperforms 45.71% of its industry peers.
With a decent Return On Invested Capital value of 4.16%, SLP is doing good in the industry, outperforming 71.43% of the companies in the same industry.
SLP had an Average Return On Invested Capital over the past 3 years of 3.61%. This is below the industry average of 6.61%.
The last Return On Invested Capital (4.16%) for SLP is above the 3 year average (3.61%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.05% | ||
| ROE | -51.86% | ||
| ROIC | 4.16% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
1.3 Margins
SLP has a better Operating Margin (8.20%) than 82.86% of its industry peers.
In the last couple of years the Operating Margin of SLP has declined.
The Gross Margin of SLP (58.38%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SLP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.2% | ||
| PM (TTM) | N/A | ||
| GM | 58.38% |
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SLP is destroying value.
The number of shares outstanding for SLP has been increased compared to 1 year ago.
The number of shares outstanding for SLP has been increased compared to 5 years ago.
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
SLP has an Altman-Z score of 33.27. This indicates that SLP is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 33.27, SLP belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 33.27 |
ROIC/WACC0.44
WACC9.54%
2.3 Liquidity
A Current Ratio of 7.67 indicates that SLP has no problem at all paying its short term obligations.
The Current ratio of SLP (7.67) is better than 88.57% of its industry peers.
SLP has a Quick Ratio of 7.67. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 7.67, SLP belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.67 | ||
| Quick Ratio | 7.67 |
3. Growth
3.1 Past
SLP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.37%, which is quite good.
Measured over the past 5 years, SLP shows a small growth in Earnings Per Share. The EPS has been growing by 1.07% on average per year.
SLP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.09%.
Measured over the past years, SLP shows a quite strong growth in Revenue. The Revenue has been growing by 13.74% on average per year.
EPS 1Y (TTM)18.37%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%-175%
Revenue 1Y (TTM)13.09%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-6.24%
3.2 Future
Based on estimates for the next years, SLP will show a very strong growth in Earnings Per Share. The EPS will grow by 22.12% on average per year.
Based on estimates for the next years, SLP will show a quite strong growth in Revenue. The Revenue will grow by 10.24% on average per year.
EPS Next Y-29.91%
EPS Next 2Y-9.53%
EPS Next 3Y24.19%
EPS Next 5Y22.12%
Revenue Next Year1.5%
Revenue Next 2Y4.18%
Revenue Next 3Y7.55%
Revenue Next 5Y10.24%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 33.05, which means the current valuation is very expensive for SLP.
Based on the Price/Earnings ratio, SLP is valued a bit cheaper than 74.29% of the companies in the same industry.
SLP is valuated rather expensively when we compare the Price/Earnings ratio to 26.56, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 47.16, the valuation of SLP can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SLP indicates a somewhat cheap valuation: SLP is cheaper than 62.86% of the companies listed in the same industry.
SLP is valuated expensively when we compare the Price/Forward Earnings ratio to 23.79, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.05 | ||
| Fwd PE | 47.16 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SLP is valued a bit cheaper than the industry average as 65.71% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, SLP is valued a bit cheaper than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.81 | ||
| EV/EBITDA | 23.96 |
4.3 Compensation for Growth
SLP's earnings are expected to grow with 24.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)30.95
EPS Next 2Y-9.53%
EPS Next 3Y24.19%
5. Dividend
5.1 Amount
SLP has a yearly dividend return of 0.61%, which is pretty low.
SLP's Dividend Yield is rather good when compared to the industry average which is at 0.53. SLP pays more dividend than 94.29% of the companies in the same industry.
With a Dividend Yield of 0.61, SLP pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
SLP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-9.53%
EPS Next 3Y24.19%
19.17
-0.34 (-1.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners78.65%
Inst Owner Change-5.94%
Ins Owners17.31%
Ins Owner Change-0.64%
Market Cap386.08M
Revenue(TTM)79.18M
Net Income(TTM)-64.72M
Analysts80
Price Target23.46 (22.38%)
Short Float %7.66%
Short Ratio2.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)180.86%
Min EPS beat(2)40.59%
Max EPS beat(2)321.12%
EPS beat(4)3
Avg EPS beat(4)67.94%
Min EPS beat(4)-90.66%
Max EPS beat(4)321.12%
EPS beat(8)4
Avg EPS beat(8)33%
EPS beat(12)5
Avg EPS beat(12)12.67%
EPS beat(16)8
Avg EPS beat(16)15.11%
Revenue beat(2)2
Avg Revenue beat(2)0.99%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.36%
Revenue beat(4)3
Avg Revenue beat(4)0.73%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)0.86%
Revenue beat(12)6
Avg Revenue beat(12)-0.85%
Revenue beat(16)10
Avg Revenue beat(16)0.61%
PT rev (1m)0%
PT rev (3m)-9.21%
EPS NQ rev (1m)43.48%
EPS NQ rev (3m)43.48%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.59%
Revenue NQ rev (1m)1.6%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.05 | ||
| Fwd PE | 47.16 | ||
| P/S | 4.88 | ||
| P/FCF | 26.81 | ||
| P/OCF | 21.3 | ||
| P/B | 3.09 | ||
| P/tB | 7.44 | ||
| EV/EBITDA | 23.96 |
EPS(TTM)0.58
EY3.03%
EPS(NY)0.41
Fwd EY2.12%
FCF(TTM)0.72
FCFY3.73%
OCF(TTM)0.9
OCFY4.69%
SpS3.93
BVpS6.2
TBVpS2.58
PEG (NY)N/A
PEG (5Y)30.95
Graham Number8.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.05% | ||
| ROE | -51.86% | ||
| ROCE | 5.18% | ||
| ROIC | 4.16% | ||
| ROICexc | 5.61% | ||
| ROICexgc | 26.12% | ||
| OM | 8.2% | ||
| PM (TTM) | N/A | ||
| GM | 58.38% | ||
| FCFM | 18.19% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
ROICexc(3y)6.84%
ROICexc(5y)12.7%
ROICexgc(3y)60.47%
ROICexgc(5y)79.01%
ROCE(3y)4.51%
ROCE(5y)5.69%
ROICexgc growth 3Y-33.77%
ROICexgc growth 5Y-24.05%
ROICexc growth 3Y-37.37%
ROICexc growth 5Y-22.33%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.34% | ||
| Cap/Sales | 4.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 123.28% | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.67 | ||
| Quick Ratio | 7.67 | ||
| Altman-Z | 33.27 |
F-Score5
WACC9.54%
ROIC/WACC0.44
Cap/Depr(3y)77.49%
Cap/Depr(5y)94.25%
Cap/Sales(3y)6%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.37%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%-175%
EPS Next Y-29.91%
EPS Next 2Y-9.53%
EPS Next 3Y24.19%
EPS Next 5Y22.12%
Revenue 1Y (TTM)13.09%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-6.24%
Revenue Next Year1.5%
Revenue Next 2Y4.18%
Revenue Next 3Y7.55%
Revenue Next 5Y10.24%
EBIT growth 1Y5.89%
EBIT growth 3Y-24.21%
EBIT growth 5Y-10.96%
EBIT Next Year143.92%
EBIT Next 3Y43.31%
EBIT Next 5Y28.01%
FCF growth 1Y59.7%
FCF growth 3Y1.12%
FCF growth 5Y11.57%
OCF growth 1Y36.08%
OCF growth 3Y0.42%
OCF growth 5Y10.69%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
What is the valuation status for SLP stock?
ChartMill assigns a valuation rating of 3 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Overvalued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What are the PE and PB ratios of SIMULATIONS PLUS INC (SLP) stock?
The Price/Earnings (PE) ratio for SIMULATIONS PLUS INC (SLP) is 33.05 and the Price/Book (PB) ratio is 3.09.
Can you provide the dividend sustainability for SLP stock?
The dividend rating of SIMULATIONS PLUS INC (SLP) is 3 / 10 and the dividend payout ratio is 0%.